U.S. flag

An official website of the United States government

NM_000760.4(CSF3R):c.2422G>A (p.Glu808Lys) AND not provided

Germline classification:
Benign/Likely benign (2 submissions)
Last evaluated:
Jul 1, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003222007.14

Allele description [Variation Report for NM_000760.4(CSF3R):c.2422G>A (p.Glu808Lys)]

NM_000760.4(CSF3R):c.2422G>A (p.Glu808Lys)

Gene:
CSF3R:colony stimulating factor 3 receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.3
Genomic location:
Preferred name:
NM_000760.4(CSF3R):c.2422G>A (p.Glu808Lys)
HGVS:
  • NC_000001.11:g.36466446C>T
  • NG_016270.1:g.21463G>A
  • NM_000760.4:c.2422G>AMANE SELECT
  • NM_156039.3:c.2503G>A
  • NM_172313.3:c.2247+175G>A
  • NP_000751.1:p.Glu808Lys
  • NP_724781.1:p.Glu835Lys
  • LRG_144t1:c.2503G>A
  • LRG_144t2:c.2422G>A
  • LRG_144:g.21463G>A
  • LRG_144p1:p.Glu835Lys
  • LRG_144p2:p.Glu808Lys
  • NC_000001.10:g.36932047C>T
  • NM_000760.3:c.2422G>A
Protein change:
E808K
Links:
dbSNP: rs146617729
NCBI 1000 Genomes Browser:
rs146617729
Molecular consequence:
  • NM_172313.3:c.2247+175G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000760.4:c.2422G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_156039.3:c.2503G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003916443CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Benign
(Jul 1, 2024)
germlineclinical testing

Citation Link,

SCV005263592Breakthrough Genomics, Breakthrough Genomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benigngermlinenot provided

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes2not providednot providednot providednot providedclinical testing, not provided

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From CeGaT Center for Human Genetics Tuebingen, SCV003916443.13

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided

Description

CSF3R: BP4, BS1, BS2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not providednot providednot provided

From Breakthrough Genomics, Breakthrough Genomics, SCV005263592.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024